MP59-08 FOLLOW-UP OF MIT FAMILY TRANSLOCATION RCC IN YOUNG ADULTS

Shudong Zhang,Lulin Ma,Shaohui Deng
DOI: https://doi.org/10.1016/j.juro.2018.02.1860
2018-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy VI1 Apr 2018MP59-08 FOLLOW-UP OF MIT FAMILY TRANSLOCATION RCC IN YOUNG ADULTS Shudong Zhang, Lulin Ma, and Shaohui Deng Shudong ZhangShudong Zhang More articles by this author , Lulin MaLulin Ma More articles by this author , and Shaohui DengShaohui Deng More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.1860AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Tumors associated with the overexpression of TFE3 and TFEB fusion products are termed MiT family translocation RCCs. Unique to this aggressive RCC subtype, up to half of all patients will present with regional or metastatic disease. Less data shows partial nephrectomy could give an adequate form of treatment for this potentially aggressive tumor type. The aim of this study was to evaluate the outcomes of a small series of patients with MiT family translocation RCC treated with nephron-sparing surgery in young adults. METHODS We describe our experiences with partial nephrectomy for the treatment of MiT family translocation renal cell carcinoma. From Jan 2014 to Sep 2017, 13 patients were pathologically confirmed MiT family translocation RCC and 10 patients were treated with partial nephrectomy. We review the demographic, clinical, pathological, and follow-up data for this series of patients. RESULTS In total, 13 patients were diagnosed with a MiT family translocation RCC. Of these patients, 10 (76.9 %) underwent treatment with partial nephrectomy for an incidentally detected small renal mass with a mean imaging diameter of 3.1cm (range, 1.9-8.0 cm). The cohort consisted of 3 men and 7 women, with a mean age at presentation of 22.8 years (range, 15-33 years). The diagnosis of a translocation RCC was confirmed 7 (70%) patients were diagnosed with an Xp11.2 translocation RCC and 3 (30%) patient with a t(6;11) translocation RCC. No case had a positive surgical margin or invasion into the renal fat. During a mean follow-up of 18.7 months, all patients were alive without evidence of disease. CONCLUSIONS At short-term follow-up, nephron-sparing surgery appears to be an effective and safe treatment option for young patients with MiT family translocation RCCs. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e784 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Shudong Zhang More articles by this author Lulin Ma More articles by this author Shaohui Deng More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?